Chelator-Free Labeling of Layered Double Hydroxide Nanoparticles for in Vivo PET Imaging

Layered double hydroxide (LDH) nanomaterial has emerged as a novel delivery agent for biomedical applications due to its unique structure and properties. However, in vivo positron emission tomography (PET) imaging with LDH nanoparticles has not been achieved. The aim of this study is to explore chel...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scientific reports 2015-11, Vol.5 (1), p.16930, Article 16930
Hauptverfasser: Shi, Sixiang, Fliss, Brianne C., Gu, Zi, Zhu, Yian, Hong, Hao, Valdovinos, Hector F., Hernandez, Reinier, Goel, Shreya, Luo, Haiming, Chen, Feng, Barnhart, Todd E., Nickles, Robert J., Xu, Zhi Ping, Cai, Weibo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Layered double hydroxide (LDH) nanomaterial has emerged as a novel delivery agent for biomedical applications due to its unique structure and properties. However, in vivo positron emission tomography (PET) imaging with LDH nanoparticles has not been achieved. The aim of this study is to explore chelator-free labeling of LDH nanoparticles with radioisotopes for in vivo PET imaging. Bivalent cation 64 Cu 2+ and trivalent cation 44 Sc 3+ were found to readily label LDH nanoparticles with excellent labeling efficiency and stability, whereas tetravalent cation 89 Zr 4+ could not label LDH since it does not fit into the LDH crystal structure. PET imaging shows that prominent tumor uptake was achieved in 4T1 breast cancer with 64 Cu-LDH-BSA via passive targeting alone (7.7 ± 0.1%ID/g at 16 h post-injection; n = 3). These results support that LDH is a versatile platform that can be labeled with various bivalent and trivalent radiometals without comprising the native properties, highly desirable for PET image-guided drug delivery.
ISSN:2045-2322
2045-2322
DOI:10.1038/srep16930